Lake Street Starts Kazia Therapeutics (KZIA) at Buy

Lake Street initiates coverage on Kazia Therapeutics (NASDAQ: KZIA) with a Buy rating and a price target of $32.00.

For an analyst ratings summary and ratings history on Kazia Therapeutics click here. For more ratings news on Kazia Therapeutics click here.

Shares of Kazia Therapeutics closed at $11.50 yesterday.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Robinhood Markets (HOOD) PT Raised to $130 at Cantor Fitzgerald
• NewAmsterdam Pharma (NAMS) call put ratio 1 call to 4.8 puts with a focus on 2K contracts of January 25 puts